Alto Neuroscience Statistics
NYSE: ANROHealth CareBiotechnology: Pharmaceutical PreparationsUSD
25.37-1.14 (-4.30%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Alto Neuroscience by the numbers
Alto Neuroscience has a market capitalization of $1.02 billion based on 40.11M shares outstanding. With trailing EPS of $-2.32, Alto Neuroscience is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.8% below its 50-day average and 1.5% above its 200-day average.
Average daily trading volume is 614.92K shares, or about $15.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ANRO valuation vs. peer median
| Metric | ANRO | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.02B | $1.01B | +1% |
| Avg. volume | 614.92K | 880.51K | -30% |
Peer median across 8 companies: CTY, NKTR, OMER, JBIO, SPTX, CYRX, KARD, MLTX.
Valuation
- Market cap
- $1.02B
- EPS (TTM)
- $-2.32
- Shares outstanding
- 40.11M
Price and trading
- Previous close
- 26.51
- Open
- 25.76
- Day range
- 24.40 – 26.48
- 52-week range
- 12.51 – 37.48
- 52-week change
- +91.47%
- Beta
- —
- Volume
- 522.53K
- Average volume
- 614.92K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 1.02B
- Forward Pe
- -8.58
- Eps
- -2.32
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 37.48
- Week52 Low
- 12.51
- Avg Volume
- 614.92K
- Shares Outstanding
- 40.11M
- Ma50
- 25.58
- Ma200
- 25.00
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -32.31%
- Pct From52w Low
- 102.80%